BioStem Technologies (OTCMKTS:BSEM) Issues Earnings Results, Beats Estimates By $0.01 EPS

BioStem Technologies (OTCMKTS:BSEM) released its earnings results on Tuesday. The company reported 0.32 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of 0.31 by 0.01, Zacks reports. The firm had revenue of 82.56 million for the quarter, compared to the consensus estimate of 78.22 million.

BioStem Technologies Stock Up 1.1 %

Shares of OTCMKTS:BSEM traded up 0.26 during mid-day trading on Wednesday, reaching 24.98. 170,900 shares of the stock were exchanged, compared to its average volume of 32,205. The stock’s 50 day simple moving average is 12.75 and its 200-day simple moving average is 10.44. BioStem Technologies has a one year low of 2.34 and a one year high of 28.26. The company has a market cap of $415.17 million, a P/E ratio of 63.38 and a beta of -0.36.

About BioStem Technologies

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.